Dr. Reddy's Laboratories Limited (DRREDDY) Share Analysis
NSE · Healthcare · Pharmaceuticals
Dr. Reddy's Laboratories Limited (NSE: DRREDDY) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 100, NIFTY 200, NIFTY 50. As of 21 Sep 2026, the share price was ₹1,185.00, market capitalisation ₹98,910 Cr, P/E 30.7, ROE 11.2%.
Get the AI verdict on DRREDDY: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
DRREDDY price and valuation
- Share price
- ₹1,185.00
- Market cap
- ₹98,910 Cr
- P/E ratio
- 30.7
- P/B ratio
- 2.61
- EPS
- ₹38.61
- Book value per share
- ₹454.00
- Dividend yield
- 0.68%
DRREDDY profitability and growth
- ROE
- 11.2%
- ROCE
- 13%
- Debt to equity
- 0.19
- Revenue growth (3 yr)
- 11%
- Revenue growth (5 yr)
- 12%
- Profit growth (3 yr)
- -4%
- Profit growth (5 yr)
- 15%
DRREDDY 52-week range
- 52-week high
- ₹1,414.90
- 52-week low
- ₹1,101.00
- Face value
- ₹1.00
DRREDDY shareholding pattern
- Promoters
- 26.63%
- FIIs
- 20.67%
- DIIs
- 31.75%
- Public
- 20.76%
Index membership: NIFTY 100, NIFTY 200, NIFTY 50, NIFTY 500, NIFTY Healthcare Index, NIFTY Pharma, NIFTY Quality 30.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.